Just last week there was another clinical trial announced with botox being used for incontinence with clinical trials taking place in the UK and now more news about the use for headaches, a decrease in the number of days a headache lasts. BD 
Results from the first clinical trial indicated no significant difference in the reduction of headache episodes between patients receiving Botox and the placebo. However, the study showed a decrease in "headache days," which the company says is the FDA's preferred efficacy measure; it was significantly greater in patients receiving Botox. Allergan said it hopes to file a license application with the U.S. Food and Drug Administration by the middle of next year to approve Botox for chronic migraine treatment. Allergan said full results from its trials would be published next year.
0 comments :
Post a Comment